An Efficient Photodynamic Therapy Treatment for Human Pancreatic Adenocarcinoma

The article was published in the Journal of Clinical Medicine under the special issue "The past, present and future of photodynamic therapy for cancer".

17th Annual Congress of the European Society for Photodynamic Therapy

OncoThAI will attend the 17th Congress of the European Society for Photodynamic Therapy in Nice, France On March 16th and 17th 2018.

Industrial development of PhoS-Istos project

Following the success of the PhoS-Istos European project, MBD Texinov will propose a commercial solution for the treatment of actinic keratoses by PDT.

Special issue of the Lasers in Surgery and Medicine journal

This special issue dedicated to the photodynamic therapy presents 3 studies led by the OncoThAI laboratory.

English Channel swimming and pleural cancer

On the occasion of Véronique Fresnel's sporting achievement, Prof. Arnaud Scherpereel described the various progress made in the treatment of malignant pleural mesothelioma.

Enrollment phase of INDYGO is now successfully achieved

After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial

Analysis phase of PHOS-ISTOS clinical trial is now achieved

This phase II clinical trial aims to treat actinic keratosis with photodynamic therapy.

Interview of Pr. Mordon during the EADV congress

Presentation of light emiting frabrics for the photodynamic treatment of actinic keratosis.

Photodynamic Therapy and Photodiagnosis Update 2020

Save the date: Update PDT-PDD 2020 will be held in Nancy, France!

Photodynamic Therapy and Photodiagnosis Update – September 2018

OncoThAI attended the European Photodynamic Therapy and Photodiagnosis Update conference from September 18th to 22nd 2018 in Kochel (Germany)

Rare diseases foundation and OncoThAI

OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord

Photodynamic Therapy and OncoThAI illustrated in Nature journal

The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal

OncoThAI will attend the 2018 EANS congress in Brussels

The INDYGO clinical trial presented during the annual EANS meeting

Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Myrian® Studio Challenge 2018

Third place for OncoThAI

A new thesis in progress

The thesis project "Design of a light emitting fabric dedicated to intracavitary photodynamic therapy" received a favorable opinion from the ANRT for CIFRE funding.

18th Annual Congress of the European Society for Photodynamic Therapy

OncoThAI will attend the 18th Congress of the European Society for Photodynamic Therapy in Brussels, France On March 8th and 9th 2019.

17th International Photodynamic Association World Congress

OncoThAI will attend the next International Photodynamic Association world congress in Boston and will present 14 papers introducing the most recent results of the lab.

The Cancéropole Nord-Ouest supports the project "Photodynamic immunotherapy on tumor organoids for ovarian epithelial cancers"

Martha Baydoun, a postdoctoral fellow, has been selected by the call for projects Mobility to develop this research.

OncoThAI obtains a grant from the University of Lille and the Region Hauts de France to support a PhD thesis on the development of a medical device for ovarian cancer treatment

The thesis project "Development of a light emitting fabric for the treatment of peritoneal carcinomatosis of ovarian origin by intracavitary photodynamic therapy" received the favorable opinion of [...]

2nd edition of the French Day on Photodynamic Therapy

This day will be held in Lille on November 28, 2019.

Start of the PAGETEX clinical trial

The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.

Second annual fluorescence-guided surgery brain tumor symposium

Pr. Nicolas Reyns will present our latest breakthroughs in the glioblastoma treatment.

Thesis defense of Claire Vicentini

Her thesis deals with the use of photodynamic therapy in dermatology.

Award ceremony for the best oral presentation and best poster

 Congratulations to Ludivine LARUE, Isabelle TOUBIA and Mathilde CHAMPEAU for their brilliant presentations of their research work.

Light emitting fabrics in dermatology

Prof. Mortier presented this technology on Europe 1 radio

Nomination of Pr. Serge Mordon as Editorial Board Member of Phamarceuticals

Pr. Serge Mordon was invited to join the Board of Pharmaceuticals. 

Europe 1 Health Trophy, 2020 edition: OncoThAI in the spotlight

OncoThAI's  research work is named in the "Health Trophies" category with the FLUXMEDICARE device manufactured and marketed by the company TEXINOV

OncoThAI will be present at EuroPDT, February 28-29, 2020, Seville, Spain

OncoThAI will be present in Seville at the next congress organized by the European Society of Photodynamic Therapy.

Mathilde CHAMPEAU has received an award for her oral communication at the EUROPDT congress in Seville

Prize awarded at the 19th Annual Congress of the European Society for Photodynamic Therapy, 28-29 February, Seville, Spain

Two articles published in the French journal médecine/sciences

The revolution of immuno-oncology therapy: review of immune checkpoint inhibitors efficacy & specificities for the physicians

A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid

The article entitled "A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid" By Mathilde CHAMPEAU and al is now online. This project is performed thanks to a collaboration [...]

Hemerion Therapeutics: winner of the ILab 2020 competition

  Hemerion Therapeutics (, is a start-up spin-off from the OncoThAI laboratory (Pr. S. Mordon). Hemerion becomes the winner of the ILab 2020 French competition. Hemerion [...]

Visit of OncoThAi by an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.

On September 3, 2020, OncoThAI had the honor to welcome, an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.

Meeting to set up the BUBOLight® clinical trial

The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]

Dr. Henri AZAIS, Surgeon - Gynecologist, defended his HDR (accreditation to direct research) on September 21, 2020

  Dr. Henri AZAIS, defended on September 22 at the Faculty of Medicine of Lille, the accreditation to direct research (HDR). Much of his presentation focused on his research project at OncoThAI [...]

Notice: Undefined index: HTTP_REFERER in /home/dgecukh/www/templates/oncothai/html/com_tags/tag/default_items.php on line 143